BI 1387446
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 1387446, covering 2025-06-12 to 2025-06-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors) [Phase 1]